Table 5. Summary of patient comorbidities for vaccinated patients.
Author (Year) | Total number vaccinated | N (%) chronic kidney disease | N (%) Diabetes | N (%) Chronic lung disease | N (%) cardiovascular disease | N (%) Immunodeficiency disorder | N (%) Neuromuscular/Neurological disorder |
Naleway (2021) [12] | 344,848 | 32 (0.009) | 24 (0.007) | 24 (0.007) | - | - | - |
Johnson (2022) [13] | 2,866,517 | - | - | - | - | - | 10 (0.0003) |
Danza (2022) [14] | 281,038 | - | - | - | - | - | - |
Olson (2022) [15] | 345 | - | 28 (8.1) | 81 (23.5) | 27 (7.8) | - | - |
Griffin (2021) [16] | 12,326 | - | - | - | - | - | - |
Tenforde (2021) [17] | 314 | - | 112 (35.7) | 100 (31.8) | 236 (75.2) | 128 (40.8) | - |
Xu (2021) [18] | 6,398,361 | - | - | - | - | - | - |